Notes
cystathionine beta-synthase (CBS); 5,10-methylene-tetrahydrofolate reductase (MTHFR)
Reference
PHARMAC. Decision to list oral betaine for rare disorder. Internet Document : 21 Dec 2016. Available from: URL: https://www.pharmac.govt.nz/news/notification-betaine/
Rights and permissions
About this article
Cite this article
PHARMAC lists oral betaine for rare disorder. PharmacoEcon Outcomes News 769, 38 (2017). https://doi.org/10.1007/s40274-017-3674-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3674-8